{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:29:28Z","timestamp":1793298568474,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.amjmed.2008.10.028","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T04:39:57Z","timestamp":1236659997000},"page":"215-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["The Management of Hyperkalemia in Patients with Cardiovascular Disease"],"prefix":"10.1016","volume":"122","author":[{"given":"Apurv","family":"Khanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2008.10.028_bib1","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-138-11-200306030-00013","article-title":"Pharmacotherapy for heart failure in patients with renal insufficiency","volume":"138","author":"Shilpak","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0002-9343(03)00435-2","article-title":"Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction","volume":"115","author":"Rodrigues","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib4","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2008.10.028_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1525-139X.2007.00312.x","article-title":"Management of hyperkalemia in dialysis patients","volume":"20","author":"Putcha","year":"2007","journal-title":"Semin Dial"},{"key":"10.1016\/j.amjmed.2008.10.028_bib6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM198004033021404","article-title":"Active transport of sodium and potassium ions: Mechanism, function and regulation","volume":"302","author":"Sweadner","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib7","first-page":"82","article-title":"Regulation of Na+ and K+ transport by mineralocorticoids","volume":"7","author":"Stanton","year":"1987","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.amjmed.2008.10.028_bib8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.281.6238.485","article-title":"Rapid poisoning with slow-release potassium","volume":"2","author":"Illingworth","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.amjmed.2008.10.028_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0735-6757(92)90058-6","article-title":"Fatal hyperkalemia from a salt substitute","volume":"10","author":"Restuccio","year":"1992","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib10","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJM198305123081919","article-title":"High potassium in low sodium soups","volume":"308","author":"Bay","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib11","first-page":"888","article-title":"Hyperkalemia","author":"Rose","year":"2001"},{"key":"10.1016\/j.amjmed.2008.10.028_bib12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ki.1990.47","article-title":"Adrenergic modulation of potassium metabolism in uremia","volume":"37","author":"Castellino","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2008.10.028_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2796.2006.01745.x","article-title":"New roles for old enzyme: Na,K-ATPase emerges as an interesting drug target","volume":"261","author":"Aperia","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM197410102911508","article-title":"Massive intravenous digoxin overdosage","volume":"291","author":"Reza","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib15","first-page":"4070","article-title":"Hyperkalemia: a complication of warm heart surgery","volume":"4067-","author":"Kao","year":"1993","journal-title":"Can J Anesth"},{"key":"10.1016\/j.amjmed.2008.10.028_bib16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0002-9343(81)90182-0","article-title":"Changes in plasma potassium concentration during acute acid-base disturbances","volume":"71","author":"Adrogue","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMra035279","article-title":"Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system","volume":"351","author":"Palmer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib18","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1681\/ASN.V641134","article-title":"Hyperkalemia in end-stage renal disease: mechanisms and management","volume":"6","author":"Allon","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjmed.2008.10.028_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2710.2005.00638.x","article-title":"Clinical factors associated with hyperkalemia in patients with congestive heart failure","volume":"30","author":"Ramadan","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.amjmed.2008.10.028_bib20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjcard.2004.04.059","article-title":"Usefulness of spironolactone in a specialized heart failure clinic","volume":"94","author":"Sligl","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2008.10.028_bib22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0002-9343(82)90415-6","article-title":"Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril","volume":"73","author":"Textor","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1210\/endo-125-1-486","article-title":"Production of renin, angiotensin II, and aldosterone by adrenal explant cultures: response to potassium and converting enzyme inhibition","volume":"125","author":"Shier","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.amjmed.2008.10.028_bib24","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1517\/14656566.5.12.2573","article-title":"Eplerenone in hypertension","volume":"5","author":"Burgess","year":"2004","journal-title":"Expert Opin Pharmcother"},{"key":"10.1016\/j.amjmed.2008.10.028_bib25","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/ndt\/gfg295","article-title":"Hyperkalemia in congestive heart failure patients using ACE inhibitors and spironolactone","volume":"18","author":"Cruz","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjmed.2008.10.028_bib26","first-page":"198","article-title":"Potassium sparing diuretics","volume":"10","author":"Horisberger","year":"1987","journal-title":"Renal Physiol"},{"key":"10.1016\/j.amjmed.2008.10.028_bib27","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.289.13.1652","article-title":"Drug-drug interactions among elderly patients hospitalized for drug toxicity","volume":"289","author":"Juurlink","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2008.10.028_bib28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9343(99)80017-5","article-title":"Heparin induced aldosterone suppression and hyperkalemia","volume":"98","author":"Oster","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0755-4982(04)98637-X","article-title":"Renal and cardiovascular effects of non-steroidal anti-inflammatory and selective cox-2 inhibitors","volume":"33","author":"Deray","year":"2004","journal-title":"Presse Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib30","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1172\/JCI109615","article-title":"Attenuation of angiotensin II and III induced aldosterone release by prostaglandin synthesis inhibitors","volume":"64","author":"Campbell","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjmed.2008.10.028_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/bmj.291.6488.107","article-title":"Incidence of hyperkalemia induced by indomethacin in a hospital population","volume":"291","author":"Zimran","year":"1985","journal-title":"Br Med J"},{"key":"10.1016\/j.amjmed.2008.10.028_bib32","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa0708379","article-title":"Aliskiren combined with losartan in type 2 diabetes and nephropathy","volume":"358","author":"Parving","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib33","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2008.10.028_bib34","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib35","first-page":"40","article-title":"Hyperkalemia revisited","volume":"33","author":"Parham","year":"2006","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.amjmed.2008.10.028_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ageing\/32.1.114","article-title":"Hyperkalemic paralysis","volume":"32","author":"Muensterer","year":"2003","journal-title":"Age Ageing"},{"key":"10.1016\/j.amjmed.2008.10.028_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.resuscitation.2005.11.002","article-title":"Potassium disorders\u2014clinical spectrum and emergency management","volume":"70","author":"Alfonzo","year":"2006","journal-title":"Resuscitation"},{"key":"10.1016\/j.amjmed.2008.10.028_bib38","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1152\/ajplegacy.1939.127.3.430","article-title":"Factors affecting the toxicity of potassium","volume":"127","author":"Winkler","year":"1939","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjmed.2008.10.028_bib39","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ki.1990.284","article-title":"Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients","volume":"38","author":"Allon","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2008.10.028_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0272-6386(12)80110-7","article-title":"Extrarenal potassium tolerance in chronic renal failure","volume":"18","author":"Salem","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjmed.2008.10.028_bib41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/emj.17.3.188","article-title":"The management of hyperkalemia in the emergency department","volume":"17","author":"Ahee","year":"2000","journal-title":"J Accid Emerg Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0736-4679(03)00133-1","article-title":"Levalbuterol is as effective as racemic albuterol in lowering serum potassium","volume":"25","author":"Pancu","year":"2003","journal-title":"J Emerg Med"},{"key":"10.1016\/j.amjmed.2008.10.028_bib43","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/ndt\/gfg323","article-title":"Controversial issues in the treatment of hyperkalemia","volume":"18","author":"Kamel","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjmed.2008.10.028_bib44","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1681\/ASN.V9101924","article-title":"Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal failure","volume":"10","author":"Gruy-Kapral","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjmed.2008.10.028_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/ndt\/16.1.78","article-title":"Low potassium and glucose free dialysis maintains urea but enhances potassium removal","volume":"16","author":"Zehnder","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjmed.2008.10.028_bib46","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.jhh.1000890","article-title":"Severe hyperkalemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction","volume":"13","author":"Ray","year":"1999","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.amjmed.2008.10.028_bib47","first-page":"593","article-title":"Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule","volume":"56","author":"Meneton","year":"2004","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjmed.2008.10.028_bib48","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1523-1755.2003.00124.x","article-title":"A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease","volume":"64","author":"Vasavada","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2008.10.028_bib49","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ki.1977.122","article-title":"Correction of hyperkalemia by bicarbonate despite constant blood pH","volume":"12","author":"Fraley","year":"1977","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2008.10.028_bib50","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/ndt\/gfg282","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and\/or serum potassium rises","volume":"18","author":"Palmer","year":"2003","journal-title":"Nephrol Dial Transplant"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934308011194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934308011194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:50:40Z","timestamp":1757580640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934308011194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0002934308011194"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2008.10.028","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Management of Hyperkalemia in Patients with Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2008.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}